June 9, 2020
Joji Nakayama, president of Japan Pharmaceutical Manufacturers Association (JPMA), on June 5 called on the government to establish a headquarters that would oversee an infectious disease control policy in both ordinary times and emergencies, saying that developing treatments and vaccines...read more